Table 6. Summary of Disease Management ROI Analysis for Diabetes.
| Number | Average Sample Size for Intervention | Average Evaluation Period (Years) | Average Per Participant Cost and Savings
|
Average ROI
|
||
|---|---|---|---|---|---|---|
| Total Benefits/Costs | ||||||
| Study Design | Cost | Savings | ||||
| RCT | 4 | 608 | 2.1 | $1,862.33 | $(1,013.25) | (0.54) |
| CBA | 1 | 3,118 | 2.0 | 580.50 | 1,294.32 | 2.23 |
| CBA | 1 | 732 | 5.0 | — | 817.50 | NA |
| Pre-Post | 2 | 3,585 | 0.9 | — | 637.50 | NA |
| Total | 8 | 2,011 | 2.5 | 610.71 | 434.02 | 0.71 |
NOTES: ROI is return on investment. RCT is randomized clinical trials. CBA is controlled, before and after study design. NA is not applicable.
SOURCE: Cornell University Institute for Policy Studies, 2004.